# Pharmacokinetics and Metabolism of Hydrocodone Bitartrate Extended-Release (HC-ER) in Subjects With Renal Impairment

> **NCT02244762** · PHASE1 · COMPLETED · sponsor: **Zogenix, Inc.** · enrollment: 37 (actual)

## Conditions studied

- Renal Impairment

## Interventions

- **DRUG:** 20 mg HC-ER
- **DRUG:** 20 mg HC-ER
- **DRUG:** 20 mg HC-ER

## Key facts

- **NCT ID:** NCT02244762
- **Lead sponsor:** Zogenix, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2022-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02244762

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02244762, "Pharmacokinetics and Metabolism of Hydrocodone Bitartrate Extended-Release (HC-ER) in Subjects With Renal Impairment". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02244762. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*